Drug abuse in athletes

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Substance Abuse and Rehabilitation 2014:5 95–105 Substance Abuse and Rehabilitation Dovepress

[1]  D. Baron,et al.  Clinical sports psychiatry : an international perspective , 2013 .

[2]  Eric D. Morse.  Sports Psychiatrists Working in College Athletic Departments , 2013 .

[3]  J. Leone,et al.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids. , 2012, Journal of athletic training.

[4]  L. Boulet,et al.  Is there a potential link between indoor chlorinated pool environment and airway remodeling/inflammation in swimmers? , 2012, Expert review of respiratory medicine.

[5]  J. Cook,et al.  A strategy to reduce illicit drug use is effective in elite Australian football , 2012, British Journal of Sports Medicine.

[6]  M. Roderick,et al.  Fédération Internationale de Football Association , 2012 .

[7]  S. Shirreffs,et al.  Nutrition for sports performance: issues and opportunities , 2011, Proceedings of the Nutrition Society.

[8]  L. Cottler,et al.  Injury, pain, and prescription opioid use among former National Football League (NFL) players. , 2011, Drug and alcohol dependence.

[9]  T. Nepusz,et al.  Self‐admitted behavior and perceived use of performance‐enhancing vs psychoactive drugs among competitive athletes , 2011, Scandinavian journal of medicine & science in sports.

[10]  W. Edmonds,et al.  Counseling Athletes Who Use Performance-Enhancing Drugs: A New Conceptual Framework Linked to Clinical Practice , 2010 .

[11]  J. P. Higgins,et al.  Energy beverages: content and safety. , 2010, Mayo Clinic proceedings.

[12]  M. Thevis,et al.  Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. , 2010, Drug testing and analysis.

[13]  A. Petróczi,et al.  Potentially fatal new trend in performance enhancement: a cautionary note on nitrite , 2010, Journal of the International Society of Sports Nutrition.

[14]  S. Basaria.  Androgen abuse in athletes: detection and consequences. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  Jeffrey R Stout,et al.  Effects of Four Weeks of High-Intensity Interval Training and Creatine Supplementation on Critical Power and Anaerobic Working Capacity in College-Aged Men , 2009, Journal of strength and conditioning research.

[16]  E. Eichner,et al.  Stimulants in sports. , 2008, Current sports medicine reports.

[17]  A. Green,et al.  Comorbid Psychiatric and Substance Abuse Disorders: Recent Treatment Research , 2008, Substance abuse.

[18]  R. Summers,et al.  The rush to adrenaline: drugs in sport acting on the β‐adrenergic system , 2008, British journal of pharmacology.

[19]  S. Elliott.  Erythropoiesis‐stimulating agents and other methods to enhance oxygen transport , 2008, British journal of pharmacology.

[20]  David Handelsman.  Indirect androgen doping by oestrogen blockade in sports , 2008, British journal of pharmacology.

[21]  P. Sönksen,et al.  Growth hormone, IGF‐I and insulin and their abuse in sport , 2008, British journal of pharmacology.

[22]  A. Pavan,et al.  Enhancement drugs and the athlete. , 2008, Neurologic clinics.

[23]  D. Baron,et al.  Doping in sports and its spread to at-risk populations: an international review. , 2007, World psychiatry : official journal of the World Psychiatric Association.

[24]  L. Avois,et al.  Cannabis and sport , 2006, British Journal of Sports Medicine.

[25]  G. Millet,et al.  Influence of “living high–training low” on aerobic performance and economy of work in elite athletes , 2006, European Journal of Applied Physiology.

[26]  David Handelsman.  Clinical review: The rationale for banning human chorionic gonadotropin and estrogen blockers in sport. , 2006, The Journal of clinical endocrinology and metabolism.

[27]  K. Judge,et al.  Can knowledge protect against acute mountain sickness? , 2005, Journal of public health.

[28]  D. McDuff,et al.  Substance use in athletics: a sports psychiatry perspective. , 2005, Clinics in sports medicine.

[29]  R. Dimeff,et al.  Iron and the athlete , 2005, Current sports medicine reports.

[30]  R. Meeusen,et al.  Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions , 2005, The Journal of physiology.

[31]  J. D. Branch,et al.  Effect of creatine supplementation on body composition and performance: a meta-analysis. , 2003, International journal of sport nutrition and exercise metabolism.

[32]  R. Casaburi,et al.  Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  P. Jenkins.  Doping in sport , 2002, The Lancet.

[34]  C. Yesalis,et al.  Performance Enhancing Substances in Sport and Exercise , 2002 .

[35]  R. Casaburi,et al.  Testosterone dose-response relationships in healthy young men. , 2001, American journal of physiology. Endocrinology and metabolism.

[36]  J. Metzl,et al.  Creatine use among young athletes. , 2001, Pediatrics.

[37]  Adele Cutler,et al.  Effects of dehydroepiandrosterone vs androstenedione supplementation in men. , 1999, Medicine and science in sports and exercise.

[38]  E. Schneeberger,et al.  Interstitial nephritis in a patient taking creatine. , 1999, The New England journal of medicine.

[39]  R. Haubrich,et al.  The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age‐advanced men and women , 1998, Clinical endocrinology.

[40]  W. Franke,et al.  Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. , 1997, Clinical chemistry.

[41]  T. Murray,et al.  Performance-enhancing drugs, fair competition, and Olympic sport. , 1996, JAMA.

[42]  J. Corcoran,et al.  Psychological treatment of anabolic-androgenic steroid-dependent individuals. , 1992, Journal of substance abuse treatment.

[43]  L. Goldberg,et al.  Anabolic steroid education and adolescents: do scare tactics work? , 1991, Pediatrics.

[44]  D. Fochtman.  Over the Edge , 1990, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[45]  P. Teale,et al.  Impact of the emergence of designer drugs upon sports doping testing , 2009 .

[46]  Peter Prock,et al.  Supplements and inadvertent doping - how big is the risk to athletes. , 2012, Medicine and sport science.

[47]  J. Stockman.  The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes: A Randomized Trial , 2012 .

[48]  R. Hosey,et al.  Performance-enhancing drugs snare nonathletes, too. , 2009, The Journal of family practice.

[49]  B. Strauss,et al.  Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. , 2007, International journal of sports medicine.

[50]  W. Kindermann.  Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes? , 2007, Sports medicine.

[51]  A. Moffat.  History of doping in sport , 2006 .

[52]  M. Saboorian,et al.  Creatine supplementation increases renal disease progression in Han:SPRD-cy rats. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  R. Casaburi,et al.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. , 1996, The New England journal of medicine.